![Jamie Dananberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jamie Dananberg
Technik-/Wissenschafts-/F&E-Leiter bei
ANNEXON, INC.
Vermögen: 669 814 $ am 31.05.2026
Profil
Jamie Dananberg is currently Chief Medical Officer & Executive Vice President at Annexon, Inc. since 2023 and serves as a Trustee at Keck Graduate Institute of Applied Life Sciences.
Former roles include VP-Translational Medicine & Tailored Therapeutics at Eli Lilly & Co. from 2000 to 2012, Executive Vice President at Takeda Pharmaceutical Co., Ltd. from 2012 to 2015, and Chief Medical Officer at Unity Biotechnology, Inc. from 2016 to 2023.
Education includes undergraduate and doctorate degrees from Tufts University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ANNEXON, INC. 0.08% | 02.03.2026 | 123’582 ( 0.08% ) | 669 814 $ | 31.05.2026 |
Aktive Positionen von Jamie Dananberg
| Unternehmen | Position | Beginn |
|---|---|---|
| ANNEXON, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.07.2023 |
Keck Graduate Institute of Applied Life Sciences
 Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jamie Dananberg
| Unternehmen | Position | Ende |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.04.2023 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01.10.2015 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.09.2012 |
Ausbildung von Jamie Dananberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keck Graduate Institute of Applied Life Sciences
Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Wählen Sie MarketScreener 
